Results 241 to 250 of about 25,009,725 (329)

Research on road parametric modeling and dynamic lightweighting methods driven by BIM-GIS integration. [PDF]

PLoS One
Cao Y, Liu X, Huang R, Zhu M, Wang Z, Xu P.   +5 more
europepmc   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

High-density three-dimensional integration of dynamic random-access memory using vertical dual-gate IGZO TFTs. [PDF]

Nat Commun
Liao F, Zhu Z, Li Z, Yang G, Liu M, Chen K, Lu W, Wu Z, Zhang X, Mao N, Kang BM, Shi J, Wu XS, Jin M, Liu C, Zhang J, Yu Y, Wang GL, Lu C, Yue J, Wang L, Wang J, Geng D, Lu N, Zhao C, Nathan A, Li L, Liu M.   +27 more
europepmc   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

New nurse workplace adaptation: a Walker and Avant concept analysis. [PDF]

Front Public Health
Xu L, Cong X, Wang J, Wang R, Yu M, Zhang L, Liu Y, Xu C.   +7 more
europepmc   +1 more source

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

Molecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek, Jenny Sprooten, Abhishek D. Garg   +2 more
wiley   +1 more source

Implementation and evaluation of a peer-to-peer support program in oncology: study protocol for the PaRole Onco France model. [PDF]

Arch Public Health
Busnel Y, Pomey MP, Termoz A, Christophe V, Tournigand C, Jouet E, Panse L, Cognon S, Ganter C, Villate A, Maisani P, Preau M, Haesebaert J, Proof investigators group.   +13 more
europepmc   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

AI-Driven Digital Twins for Manufacturing: A Review Across Hierarchical Manufacturing System Levels. [PDF]

Sensors (Basel)
Nguyen P, Kim M, Nichols E, Yoon HS.
europepmc   +1 more source